MGTX
MeiraGTx Holdings PLC
NASDAQ: MGTX · HEALTHCARE · BIOTECHNOLOGY
$9.22
+3.02% today
Updated 2026-04-30
Market cap
$840.42M
P/E ratio
—
P/S ratio
10.33x
EPS (TTM)
$-1.42
Dividend yield
—
52W range
$5 – $12
Volume
0.7M
MeiraGTx Holdings PLC (MGTX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.37M | $-18.06M | $-58.89M | $20.04M | $-63.97M | $-10.53M | $-73.10M | $-105.36M | $-104.50M | $-46.36M |
| Capital expenditures | $2.59M | $10.54M | $11.26M | $8.98M | $37.02M | $55.22M | $44.96M | $20.17M | $4.96M | $3.83M |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $2.81M | $2.96M | $17.88M | $15.93M | $18.42M | $20.78M | $28.62M | $27.72M | $25.19M | $22.11M |
| Free cash flow | $-16.96M | $-28.59M | $-70.15M | $11.06M | $-100.99M | $-65.75M | $-118.06M | $-125.54M | $-109.45M | $-50.19M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $69.97M | $0.00 | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $59.89M | $158.91M | $-18.26M | $-70.54M | $-22.86M | — | — | — |